These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8207563)

  • 1. Calciotropic hormones in salt-sensitive essential hypertension: 1,25-dihydroxyvitamin D and parathyroid hypertensive factor.
    Resnick LM
    J Hypertens Suppl; 1994 Jan; 12(1):S3-9. PubMed ID: 8207563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular ions in salt-sensitive essential hypertension: possible role of calcium-regulating hormones.
    Resnick LM; Gupta RK; Lewanczuk RZ; Pang PK; Laragh JH
    Contrib Nephrol; 1991; 90():88-93. PubMed ID: 1959360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium metabolism in essential hypertension: relationship to altered renin system activity.
    Resnick LM; Nicholson JP; Laragh JH
    Fed Proc; 1986 Nov; 45(12):2739-45. PubMed ID: 3533639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of parathyroid hypertensive factor.
    Lewanczuk RZ; Resnick LM; Ho MS; Benishin CG; Shan J; Pang PK
    J Hypertens Suppl; 1994 Jan; 12(1):S11-6. PubMed ID: 8207559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calciotropic hormones in human and experimental hypertension.
    Resnick LM
    Am J Hypertens; 1990 Aug; 3(8 Pt 2):171S-178S. PubMed ID: 2222965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hypertensive factor.
    Pang PK; Lewanczuk RZ; Benishin CG
    J Hypertens Suppl; 1990 Dec; 8(7):S155-9. PubMed ID: 2095385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of calcium and calcium channel blockade in essential hypertension.
    Resnick LM; Laragh JH
    J Hypertens Suppl; 1985 Dec; 3(3):S541-4. PubMed ID: 2856782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of sodium and calcium in clinical hypertension: mediating role of vitamin D metabolism.
    Resnick LM
    Adv Second Messenger Phosphoprotein Res; 1990; 24():535-41. PubMed ID: 2119657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hypertensive factor-like activity in human essential hypertension: relationship to plasma renin activity and dietary salt sensitivity.
    Resnick LM; Lewanczuk RZ; Laragh JH; Pang PK
    J Hypertens; 1993 Nov; 11(11):1235-41. PubMed ID: 8301105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade.
    Resnick LM; Gupta RK; DiFabio B; Barbagallo M; Mann S; Marion R; Laragh JH
    J Clin Invest; 1994 Sep; 94(3):1269-76. PubMed ID: 8083368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
    Campese VM; Wurgaft A; Safa M; Bianchi S
    J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure sensitivity to salt, calcium metabolism and insulin sensitivity in essential hypertension.
    Saruta T; Tominaga T; Yamakawa H; Ohno Y; Suzuki H
    Clin Exp Pharmacol Physiol; 1995 Dec; 22(12):S406-11. PubMed ID: 8846505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of parathyroid hypertensive factor secretion by vitamin D3 analogs in parathyroid cells derived from spontaneously hypertensive rats.
    Sutherland SK; Nemere I; Benishin CG
    J Cell Biochem; 2005 Sep; 96(1):97-108. PubMed ID: 15988762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium metabolism in hypertension and allied metabolic disorders.
    Resnick LM
    Diabetes Care; 1991 Jun; 14(6):505-20. PubMed ID: 1864222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary calcium supplementation on blood pressure and calciotropic hormones in mineralocorticoid-salt hypertension.
    DiPette DJ; Greilich PE; Nickols GA; Graham GA; Green A; Cooper CW; Holland OB
    J Hypertens; 1990 Jun; 8(6):515-20. PubMed ID: 2165085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum-mediated intracellular calcium changes in normotensive and hypertensive red blood cells: role of parathyroid hypertensive factor.
    Barbagallo M; Gupta RK; Lewanczuk RZ; Pang PK; Resnick LM
    J Cardiovasc Pharmacol; 1994; 23 Suppl 2():S14-7. PubMed ID: 7518539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of parathyroid hypertensive factor.
    Lewanczuk RZ; Benishin CG; Shan J; Pang PK
    J Cardiovasc Pharmacol; 1994; 23 Suppl 2():S23-6. PubMed ID: 7518541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hypertensive factor, a circulating factor in animal and human hypertension.
    Pang PK; Benishin CG; Lewanczuk RZ
    Am J Hypertens; 1991 May; 4(5 Pt 1):472-7. PubMed ID: 2069782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-calcium interactions and salt-sensitive hypertension.
    Kurtz TW; Morris RC
    Am J Hypertens; 1990 Aug; 3(8 Pt 2):152S-155S. PubMed ID: 2222961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.